VT
Vedana Therapeutics
United States · Biotech · Healthtech
Develops next-generation therapies for migraine prevention
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $46M | Alexandria Venture Investments — Role not disclosedCanaan Partners — Role not disclosedDawn Biopharma — Role not disclosedWestlake BioPartners — Role not disclosed |